Government Debates Staggered Increase in Pharmacy Remuneration
The coalition government is currently engaged in discussions regarding proposed amendments to the scale of pharmacy remuneration, specifically the phased increase of the fixed dispensing fee for pharmacies. Recent drafts from the Federal Ministry of Health suggest a two-stage increment, with the fixed fee initially set to rise to 9 euros, followed by an increase to 9.50 euros after one year of implementation.
Despite the suggested approach, there remains significant uncertainty surrounding the final structure of the remuneration system. Government representatives have indicated that while the overarching legislation and regulatory frameworks are largely agreed upon, consensus on the specifics of the fixed fee adjustment has yet to be reached. Deliberations are ongoing, with efforts underway to finalize the process in the near future.
The proposed changes are part of a broader legislative package aimed at modernizing the pharmacy sector. The Pharmacy Provision Development Act is scheduled for further consideration within the Health Committee, with a final parliamentary reading anticipated in the coming months. The intention is to align the implementation of both the regulation and the associated law, ensuring a coordinated update to the sector's legal and financial frameworks.
Members of Parliament have expressed reservations about the staggered increase, advocating instead for a full and immediate adjustment to the 9.50 euro fee, as outlined in the coalition agreement. Critics argue that a phased approach fails to meet the original political commitment to the pharmacy sector and could delay much-needed financial relief for pharmacies across the country.
The debate also includes discussions on the requirements for branch pharmacies, with some proposals suggesting reduced operational demands to support broader access to pharmaceutical services. The overall aim of the reforms is to enhance the sustainability and efficiency of pharmacy operations while ensuring consistent quality of care for patients.
In addition to the remuneration debate, the legislative process involves coordination between the Federal Ministry of Health and the Federal Ministry for Economic Affairs and Energy, both of which must formally approve the new provisions. Updates to the pharmacy operating regulations and related statutes are intended to be enacted simultaneously with the main legislation.
The outcome of these discussions will have a significant impact on the pharmacy sector, affecting both financial planning for pharmacy owners and the availability of pharmaceutical services to the public. The government is under pressure to deliver a solution that balances fiscal constraints with the need to uphold the commitments made in the coalition agreement and maintain a robust healthcare system.
As parliamentary committees continue to review the proposed measures, stakeholders within the pharmacy and healthcare sectors are closely monitoring developments. The final decision will determine not only the structure of pharmacy remuneration but also set a precedent for future reforms within the German healthcare landscape.